Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$18.1 million.

  • Medifast's Consolidated Net Income fell 237289.84% to -$18.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$18.7 million, marking a year-over-year decrease of 100591.95%. This contributed to the annual value of -$18.7 million for FY2025, which is 99468.14% down from last year.
  • Latest data reveals that Medifast reported Consolidated Net Income of -$18.1 million as of Q4 2025, which was down 237289.84% from -$2.3 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Consolidated Net Income registered a high of $47.0 million during Q2 2021, and its lowest value of -$18.1 million during Q4 2025.
  • Moreover, its 5-year median value for Consolidated Net Income was $24.8 million (2022), whereas its average is $19.5 million.
  • Within the past 5 years, the most significant YoY rise in Medifast's Consolidated Net Income was 13036.81% (2025), while the steepest drop was 237289.84% (2025).
  • Quarter analysis of 5 years shows Medifast's Consolidated Net Income stood at $34.0 million in 2021, then fell by 22.06% to $26.5 million in 2022, then crashed by 77.24% to $6.0 million in 2023, then crashed by 86.79% to $797000.0 in 2024, then crashed by 2372.9% to -$18.1 million in 2025.
  • Its Consolidated Net Income stands at -$18.1 million for Q4 2025, versus -$2.3 million for Q3 2025 and $2.5 million for Q2 2025.